Skip to content

CALMARE THERAPEUTICS Inc

Delisted

CIK 102198fmd_04GA224K5CPMB3N693SYPX130RManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Feb 01, 2010 to Dec 31, 2016, 26 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013FY2014FY2015FY2016
Total revenues3–––––
Cost of revenue100000
Gross profit210111
Compensation and benefits2–––––
Total operating expenses640111
Operating income(4)(3)(3)(2)(3)(2)
Interest expense000111
Income before taxes(4)(3)(3)(3)(4)(4)
Net income(4)(3)(3)(3)(4)(4)
Net income to common shareholders(4)–––––